Iovance Biotherapeutics, Inc. (IOVA)
3.51
-0.18
(-4.88%)
USD |
NASDAQ |
Mar 27, 16:00
3.51
0.00 (0.00%)
After-Hours: 20:00
Iovance Biotherapeutics Total Liabilities (Quarterly) : 214.59M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Orthofix Medical, Inc. | 400.61M |
| InfuSystem Holdings, Inc. | 51.73M |
| Axogen, Inc. | 92.84M |
| KalVista Pharmaceuticals, Inc. | 338.09M |
| Lantheus Holdings, Inc. | 1.138B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 913.17M |
| Shareholders Equity (Quarterly) | 698.58M |
| Debt to Equity Ratio | 0.0708 |
| Current Ratio | 3.200 |
| Net Debt Paydown Yield | 0.52% |